Travere Therapeutics, Inc. (TVTX)
USD 16.86
(-1.63%)
USD 16.86
(-1.63%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 145.23 Million | 212.01 Million | 227.49 Million | 198.32 Million | 175.33 Million | 164.24 Million |
| Cost of Revenue | 11.45 Million | 7.59 Million | 6.78 Million | 6.12 Million | 5.23 Million | 5.52 Million |
| Gross Profit | 133.78 Million | 204.42 Million | 220.7 Million | 192.19 Million | 170.1 Million | 158.71 Million |
| Operating Expenses | 472 Million | 455.98 Million | 360.21 Million | 267.57 Million | 269.91 Million | 227.41 Million |
| Selling, General and Administrative Expenses | 265.54 Million | 220.2 Million | 149.88 Million | 135.79 Million | 128.95 Million | 103.65 Million |
| Research and Development Expenses | 244.99 Million | 235.78 Million | 210.32 Million | 131.77 Million | 140.96 Million | 123.75 Million |
| Other Expenses | 11.39 Million | 974 Thousand | 231 Thousand | 1.42 Million | -314 Thousand | -474 Thousand |
| Cost and Expenses | 521.98 Million | 463.57 Million | 366.99 Million | 273.69 Million | 275.14 Million | 232.93 Million |
| Operating Income | -376.74 Million | -251.56 Million | -139.5 Million | -75.37 Million | -99.81 Million | -80.04 Million |
| Interest Expense | 11.33 Million | 11.27 Million | 20.14 Million | 19.05 Million | 18.82 Million | 9.81 Million |
| Income Tax Expense | 223 Thousand | 313 Thousand | 409 Thousand | -19.35 Million | -21 Thousand | 811 Thousand |
| Earnings before Tax | -376.11 Million | -278.16 Million | -179.68 Million | -188.79 Million | -146.44 Million | -101.86 Million |
| Net Income | -111.39 Million | -278.48 Million | -180.09 Million | -169.43 Million | -146.42 Million | -102.67 Million |
| Earnings Per Share Basic | -1.50 | -4.37 | -3.01 | -3.56 | -3.46 | -2.54 |
| Earnings Per Share Diluted | -1.50 | -4.37 | -3.01 | -3.56 | -3.46 | -2.54 |
| Weighted Average Shares Outstanding | 74.26 Million | 63.75 Million | 59.83 Million | 47.53 Million | 42.33 Million | 40.42 Million |
| Weighted Average Shares Outstanding (Diluted) | 74.26 Million | 63.75 Million | 59.83 Million | 47.53 Million | 42.33 Million | 40.43 Million |
| Gross Margin | 0.92 | 0.96 | 0.97 | 0.97 | 0.97 | 0.97 |
| EBIT Margin | -2.25 | -1.15 | -0.60 | -0.35 | -0.40 | -0.39 |
| Profit Margin | -0.77 | -1.31 | -0.79 | -0.85 | -0.84 | -0.63 |
| EBITDA | -326.24 Million | -299.42 Million | -186.67 Million | -143.95 Million | -107.21 Million | -73.38 Million |
| Earnings Before Tax Margin | -2.59 | -1.19 | -0.61 | -0.38 | -0.57 | -0.49 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 62.89 Million | 54.11 Million | 41.37 Million | 45.05 Million | 145.23 Million | 37.09 Million |
| Cost of Revenue | 12.86 Million | 12.4 Million | 1.5 Million | 16.41 Million | 56.38 Million | 1.28 Million |
| Gross Profit | 50.03 Million | 41.71 Million | 39.87 Million | 28.64 Million | 88.85 Million | 35.8 Million |
| Operating Expenses | 119.04 Million | 108.76 Million | 178.84 Million | 111.48 Million | 465.6 Million | 129.68 Million |
| Selling, General and Administrative Expenses | 65.61 Million | 54.43 Million | 64.22 Million | 52.73 Million | - | 67.8 Million |
| Research and Development Expenses | 51.67 Million | 54.33 Million | 114.62 Million | 58.74 Million | - | 60.59 Million |
| Other Expenses | 1.74 Million | -3.49 Million | 238 Thousand | 1.37 Million | 1.59 Million | 1.28 Million |
| Cost and Expenses | 119.04 Million | 121.16 Million | 180.35 Million | 127.89 Million | 521.98 Million | 129.68 Million |
| Operating Income | -54.75 Million | -67.05 Million | -139.23 Million | -82.83 Million | -376.74 Million | -89.24 Million |
| Interest Expense | -2.77 Million | 2.78 Million | 2.8 Million | 2.82 Million | 11.33 Million | -2.82 Million |
| Income Tax Expense | 84 Thousand | 85 Thousand | 191 Thousand | 68 Thousand | 223 Thousand | -12 Thousand |
| Earnings before Tax | -54.83 Million | -69.56 Million | -135.76 Million | -88.52 Million | -376.11 Million | -89.22 Million |
| Net Income | -54.81 Million | -70.4 Million | -136.06 Million | -90.17 Million | -111.39 Million | 150.73 Million |
| Earnings Per Share Basic | -0.70 | -0.91 | -1.76 | -1.18 | - | -0.99 |
| Earnings Per Share Diluted | -0.70 | -0.91 | -1.76 | -1.18 | - | -0.99 |
| Weighted Average Shares Outstanding | 77.77 Million | 77.5 Million | 77.13 Million | 76.47 Million | 74.26 Million | 76.3 Million |
| Weighted Average Shares Outstanding (Diluted) | 77.77 Million | 77.5 Million | 77.13 Million | 76.47 Million | 74.26 Million | 76.3 Million |
| Gross Margin | 0.80 | 0.77 | 0.96 | 0.64 | 0.61 | 0.97 |
| EBIT Margin | -0.87 | -1.05 | -2.97 | -1.58 | - | -2.41 |
| Profit Margin | -0.87 | -1.30 | -3.29 | -2.00 | -0.77 | 4.06 |
| EBITDA | -54.75 Million | -56.7 Million | -122.82 Million | -70.98 Million | - | -89.24 Million |
| Earnings Before Tax Margin | -0.87 | -1.24 | -3.37 | -1.84 | -2.59 | -2.41 |
ASRT
600988
BHARATWIRE
BBBMF
DCON
301165